MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of ...

Strategic Collaborations: The company's ability to establish and maintain collaborations, such as the prior agreement with ...

At Denali he led the execution of more than twenty collaborations, including partnerships with Sanofi-Genzyme ... at ImmuLogic Pharmaceutical Corp., and associate professor of rheumatology ...

GF Watts has received lecture fees and has served as an advisor to Sanofi-Aventis, Genzyme and Amgen Corporation. The authors have no other relevant affiliations or financial involvement with any ...

About the author: Jennifer Wound is a senior product manager for global marketing at Genzyme Corporation, a subsidiary of Sanofi. She recently helped to develop "Facing Fabry Together," a rare ...

The treatment of IBD has evolved significantly over the past 15 years. Historically, steroids and immunosuppressive drugs, such as methotrexate (MTX), azathioprine (AZA) and 6-mercaptopurine (6-MP) ...

Prior to joining BioAffinity in 2016 as SVP of R&D, he was associate director of science at Genzyme, now part of Sanofi. Bausta held a similar ... now part of Laboratory Corporation of America. Prior ...

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses.

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to improve drug development by speeding up clinical trial recruitment.